An Analysis of Siddha Management among COVID-19 Positive Patients of TPEC COVID Care Center, Vellore, Tamilnadu ”Feedback report

Jump To References Section

Authors

  • Government Hospital, Pernambut, Vellore – 635810, Tamil Nadu ,IN
  • District Siddha Medical Hospital, Vellore, Tamil Nadu ,IN
  • Indian Medicine and Homeopathy Department, Chennai – 600106, Tamil Nadu ,IN
  • Indian Medicine and Homeopathy Department, Chennai – 600106, Tamil Nadu ,IN
  • District Collector's Office, Vellore – 632009, Tamil Nadu ,IN

DOI:

https://doi.org/10.18311/jnr/2021/26626

Keywords:

COVID Care Center, Integrative Medicine, SARS CoV-2, Novel Corona Virus, Siddha System of Medicine

Abstract

Siddha's system of medicine is the effective one to reduce the symptoms of many viral illnesses. Siddha's system of medicine in asymptomatic, mild to moderate Covid-19 Positive patients, will make them recognize its effectiveness, reduce the symptoms, and move into the traditional approach towards the deadliest pandemic disease Covid-19. The objective of this study is to evaluate the acceptance and benefit of integrative Siddha management among the mild, moderate and asymptomatic COVID patients through a feedback questionnaire in TPEC COVID Care Center, Vellore, Tamil Nadu (TPECThanthai Periyar Engineering College). 74 asymptomatic, mild to moderate Covid-19 Positive patients were observed 7 days from 14.07.2020 to 30.07.2020 in TPEC COVID Care Center, Vellore, Tamil Nadu. During this period, Siddha medicines were administrated along with Western medicine. At the end of the period, validated feedback questionnaires were used to collect information from 74 participants for evaluating the acceptance and benefit of integrative Siddha management.In the 74 patients of TPEC COVID Care Center, Vellore, 100% were taken the given Siddha drug properly. 82.4% had the most common symptoms and 52.7% had less common symptoms. 16.2% of cases developed gastric acidity and 1.3% developed mild dyspnea as an ADR. 91.8% were recommended the Siddha system to others. 93.2% reported excellent disease progress. 90.7% of Siddha doctors quoted for 'Excellent' service on covid patients. This feedback report explores the three important significance. (a) Siddha medicine having significant effectiveness (b) Siddha medicines have safety in covid-19 patients (c) overall services of Siddha doctors are appreciatable by the patients and Siddha system is recommended to others. This analysis report helps to provide the possibility of the Siddha system for further or future clinical trials.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2021-10-01

How to Cite

Thillaivanan, S., Susikannamma, S., Parthiban, P., Ganesh, V., & Shanmugasundaram, A. (2021). An Analysis of Siddha Management among COVID-19 Positive Patients of TPEC COVID Care Center, Vellore, Tamilnadu ”Feedback report. Journal of Natural Remedies, 21(4), 351–355. https://doi.org/10.18311/jnr/2021/26626

Issue

Section

Short Communication
Received 2020-12-22
Accepted 2021-06-16
Published 2021-10-01

 

References

Gangarapu K,Sathiyarajeswaran P,Kanakavalli K, Kumar KM, Kumar DR,Shreedevi MS, et al. In silico computational screening of kabasurakudineer - official siddha formulation and JACOM - Novel Herbal Coded Formulation Against SARS-CoV-2 Spike protein [Internet].2020, Apr 13. Available from: https://ssrn.com/abstract=3574412. http:// dx.doi.org/10.2139/ssrn.3574412.

Cyranoski D. 'We need to be alert: scientists fear the second coronavirus wave as China's lockdowns ease. Nature. 2020 [Epub ahead of print]. https://doi. org/10.1038/d41586-020-00938-0

Zuo MZ, Huang YG, Ma WH, et al. Expert recommendations for tracheal intubation in critically ill patients with novel coronavirus disease. Chin Med Sci J. 2020; 35:105–9. https://doi.org/10.24920/003724

Camilla R, Mirjam S, Peter S, Gisela B, Guenter F, Claudia W, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New Engl J Med. 2020; 382(10):970–1. https://doi.org/10.1056/NEJMc2001468

Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 2020 Jan 20–28. Euro Surveill. 2020;25. https://doi. org/10.2807/1560-7917.ES.2020.25.5.2000062

Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Aug; 584(7820):257–61.

World Health Organization, Regional Office for South-East Asia traditional herbal remedies for primary health care. WHO Regional Office for South-East Asia. 2010. https://apps.who.int/iris/ handle/10665/206024

Rakulini R. Classification of 4448 Diseases in Siddha System of Medicine - A Review. Journal of Complementary and Alternative Medical Research. 2020; 9(2):46–54. https://doi.org/10.9734/ jocamr/2020/v9i230140

Available from: https://www.cdc.gov/coronavirus/ 2019-ncov/symptoms testing/symptoms.html?CDC_ A A _ ref Va l=ht t ps%3A%2F%2Fw w w.cdc.gov %2Fcoronavirus%2F2019-ncov%2Fabout%2F symptoms.html.

Azer SA. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020; 37. https://doi. org/10.1016/j.nmni.2020.100738

Most read articles by the same author(s)